PlasmaGen Biosciences secures ₹150 crore to expand into global markets
The new equity financing will support PlasmaGen Biosciences' international expansion and enhance its portfolio of plasma-derived therapeutics, following a total of ₹600 crore raised since 2010.
The new equity financing will support PlasmaGen Biosciences' international expansion and enhance its portfolio of plasma-derived therapeutics, following a total of ₹600 crore raised since 2010.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
